Prognostic value of the monoethylglycinexylidide (MEGX)-test prior to liver resection

Hepato-Gastroenterology

Volumn 55, Issue 82-83, 2008, Pages 539-543

  Lorf, T ^a   Schnitzbauer, A A ^b   Schaefers, S K H ^a   Scherer, M N ^b   Schlitt, H J ^b   Oellerich, M ^c   Becker, H ^a   Obed, Aiman ^b  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^c UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Liver resection; Liver reserve; MEGX

Indexed keywords

LIDOCAINE;

ACTINOMYCOSIS; ADULT; AGE; AGED; ARTICLE; BILE DUCT CARCINOMA; BODY MASS; CAROLI DISEASE; COLORECTAL CANCER; DEATH; DEHYDRATION; FEMALE; FIBROLAMELLAR CARCINOMA; HEMANGIOMA; HOSPITAL COST; HOSPITALIZATION; HUMAN; KLATSKIN TUMOR; LIVER ADENOMA; LIVER CANCER; LIVER CELL CARCINOMA; LIVER FUNCTION TEST; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MONOETHYLGLYCINEXYLIDIDE TEST; MORTALITY; NEPHROID METASTASIS; NODULAR HYPERPLASIA; PRIORITY JOURNAL; SARCOMATOID CARCINOMA; SURGICAL TECHNIQUE; SURVIVAL;

ADULT; AGED; FEMALE; HEPATECTOMY; HUMANS; LIDOCAINE; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; PROGNOSIS; RISK ASSESSMENT;

EID: 44349162285     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Oellerich M, Armstrong VW: The MEGX test: a tool for the real-time assessment of hepatic function. Ther Drug Monit 2001; 23(2):81-92.
2. Guengerich FP: Mechanism-based inactivation of human liver microsomal cytochrome P-450 IIIA4 by gestodene. Chem Res Toxicol 1990; 3:363-371.
3. Oellerich M, Schutz E, Polzien F: Influence of gender on the monoethylglycinexylidide test in normal subjects and liver donors. Ther Drug Monit 1994; 16:225-231.
4. Oellerich M, Raude E, Burdelski M: Monoethyl-glycinexylidide formation kinetics: a novel approach to assessment of liver function. J Clin Chem Clin Biochem 1987; 25:845-853.
5. Zotz RB, von SJ, Erhard J: Value of an extended monoethylglycinexylidide formation test and other dynamic liver function tests in liver transplant donors. Transplantation 1997; 63:538-541.
6. Olinga P, Maring JK, Groothuis GM: Value of the in vitro or in vivo monoethylglycinexylidide test for predicting liver graft function. Transplantation 1997; 64:60-65.
7. Fairchild R, Solomon H, Contis J, Kaminski D: Prognostic value of the monoethylglycinexylidide liver function test in assessing donor liver suitability. Arch Surg 1996; 131:1099-1102.
8. Woodside KJ, Merion RM, Williams TC: Prospective multivariate analysis of donor monoethylglycinexylidide (MEGX) testing in liver transplantation. Transplantation Society of Michigan Scientific Studies Committee. Clin Transplant 1998; 12:43-48.
9. Schutz E, Luy KM, Kaltefleiter M: The value of serial determination of MEGX and hyaluronic acid early after orthotopic liver transplantation. Eur J Clin Invest 1996; 26:907-916.
10. Jalan R, Plevris JN, Jalan AR: A pilot study of indocyanine green clearance as an early predictor of graft function. Transplantation 1994; 58:196-200.
11. Kanematsu T, Takenaka K, Matsumata T, Furuta T, Sugimachi K, Inokuchi: Limited hepatic resection effective for selected cirrhotic patients with primary liver cancer. Ann Surg 1984; 199(1):51-56.
12. Kinami Y, Takashima S, Miyazaki I: Hepatic resection for hepatocellular carcinoma associated with liver cirrhosis. World J Surg 1986; 10(2):294-301.
13. Fan ST, Lai EC, Lo CM, Ng IO, Wong J: Hospital mortality of major hepatectomy for hepatocellular carcinoma associated with cirrhosis. Arch Surg 1995; 130(2):198-203.
14. Oellerich M, Burdelski M, Lautz HU, Binder L, Pichlmayr R: Predictors of one-year pretransplant survival in patients with cirrhosis. Hepatology 1991; 14(6):1029-1034.
15. Oellerich M, Burdelski M, Lautz HU, Rodeck B, Duewel J, Schulz M, Schmidt FW, Brodehl J, Pichlmayr R: Assessment of pretransplant prognosis in patients with cirrhosis. Transplantation 1991; 51(4):801-806.
16. Oellerich M, Burdelski M, Ringe B, Wittekind C, Lamesch P, Lautz HU, Gubernatis G, Beyrau R, Pichlmayr R: Functional state of the donor liver and early outcome of transplantation. Transplant Proc 1991; 23:1575-1578. (No abstract available)
17. Huang YS, Lee SD, Deng JF, Wu JC, Lu RH, Lin YF, Wang YJ, Lo KJ: Measuring lidocaine metabolite-monoethylglycinexylidide as a quantitative index of hepatic function in adults with chronic hepatitis and cirrhosis. J Hepatol 1993; 19(1):140-147.
18. Lee WC, Chen MF: Assessment of hepatic reserve for indication of hepatic resection: how I do it. J Hepatobiliary Pancreat Surg 2005;12(1):23-26.
19. Ravaioli M, Grazi GL, Principe A, Ercolani G, Cescon M, Gardini A, Varotti G, Del Gaudio M, Cavallari A: Operative risk by the lidocaine test (MEGX) in resected patients for HCC on cirrhosis. Hepatogastroenterology 2003; 50(53):1552-1555.
20. Ercolani G, Grazi GL, Calliva R, Pierangeli F, Cescon M, Cavallari A, Mazziotti A: The lidocaine (MEGX) test as an index of hepatic function: its clinical usefulness in liver surgery. Surgery 2000; 127(4):464-471.
21. Zoedler T, Ebener C, Becker H, Roeher HD: Evaluation of liver function tests to predict operative risk in liver surgery. HPB Surg 1995; 9(1):13-18.
22. Gruttadauria S, Marino G, Gentile A, Sgroi AV, Fonti A, Libra S, Gruttadauria G: Unreliability of the lidocaine test as a prognostic indicator of acute liver failure: an experimental study in swine. G Chir 1999; 20:53-56.
23. Testa R, Borzone S, Campo N, Alvarez S, Caglieris S, Arzani L, Risso D, Lantieri PB, Celle G: Monoethyl-glycinexylidide formation in compensated cirrhosis: correlation with Child-Pugh score. Transplant Proc 1994; 26(6):3624-3625.
24. Oellerich M, Schutz E, Polzien F, Ringe B, Armstrong VW, Hartmann H, Burdelski M: Influence of gender on the monoethylglycinexylidide test in normal subjects and liver donors. Ther Drug Monit 1994;16(3):225-231.
25. Okamoto E, Kyo A, Yamanaka N, Tanaka N, Kuwata K: Prediction of the safe limits of hepatectomy by combined volumetric and functional measurements in patients with impaired hepatic function. Surgery 1984; 95(5):586-592.
26. Fortner JG, Lincer RM: Hepatic resection in the elderly. Ann Surg 1990; 211(2):141-145.
27. Ringe B, Bechstein WO, Raab R, Meyer HJ, Pichlmayr R: Liver resection in 157 patients with colorectal metastases. Chirurg 1990; 61(4):272-279.
28. Weimann A, Ringe B, Klempnauer J, Lamesch P, Gratz KF, Prokop M, Maschek H, Tusch G, Pichlmayr R: Benign liver tumors: differential diagnosis and indications for surgery. World J Surg 1997; 21(9):983-990.
29. Lamesch P, Ringe B, Rabe C, Oellerich M, Burdelski M, Pichlmayr R: Quantitative liver function testing as a preoperative parameter in hepatic resection. Cancer Treat Res 1994; 69:301-306.
30. Melendez J, Ferri E, Zwillman M, Fischer M, DeMatteo R, Leung D, Jarnagin W,Fong Y, Blumgart LH: Extended hepatic resection: a 6-year retrospective study of risk factors for perioperative mortality. J Am Coll Surg 2001;192(1):47-53.
31. Bismuth H, Castaing D, Houssin D: Liver resection. Indications and results. Chirurg 1985; 56(4):203-210.
32. Streit F, Niedmann PD, Shipkova M, Armstrong VW, Oellerich M: Rapid and sensitive liquid chromatography-tandem mass spectrometry method for determination of monoethylglycinexylidide. Clin Chem 2001; 47:1853-1856.